Welcome to LookChem.com Sign In|Join Free

CAS

  • or

51309-10-5

Post Buying Request

51309-10-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51309-10-5 Usage

Chemical Properties

Colorless transparent liquid

Check Digit Verification of cas no

The CAS Registry Mumber 51309-10-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,3,0 and 9 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 51309-10:
(7*5)+(6*1)+(5*3)+(4*0)+(3*9)+(2*1)+(1*0)=85
85 % 10 = 5
So 51309-10-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H21ClO/c11-9-7-5-3-1-2-4-6-8-10-12/h12H,1-10H2

51309-10-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 10-Chloro-1-decanol

1.2 Other means of identification

Product number -
Other names 10-chlorodecan-1-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51309-10-5 SDS

51309-10-5Relevant articles and documents

METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND

-

Paragraph 0196; 0197; 0198; 0199; 0200; 0201, (2019/11/05)

A halide compound having one or more carbon-carbon unsaturated bonds is catalytically reduced with substantially no dehalogenation to produce a reduced halide compound in which at least one of the one or more unsaturated bonds is reduced. Specifically provided is a method for producing a reduced halide compound including steps of: reacting a nickel compound, a zinc compound, and a borohydride compound in a solvent to obtain a reduction catalyst; and subjecting a halide compound having one or more carbon-carbon unsaturated bonds to catalytic reduction in the presence of the reduction catalyst to reduce at least one of the one or more carbon-carbon unsaturated bonds to thereby obtain a reduced halide compound.

Novel lipid-mimetic prodrugs delivering active compounds to adipose tissue

Mattarei, Andrea,Rossa, Andrea,Bombardelli, Veronica,Azzolini, Michele,La Spina, Martina,Paradisi, Cristina,Zoratti, Mario,Biasutto, Lucia

supporting information, p. 77 - 88 (2017/04/26)

Obesity and associated pathologies are a dramatically growing problem. New therapies to prevent and/or cure them are strongly needed. Adipose tissue is a logical target for pharmacological intervention, since it is now recognized to exert an important endocrine function, secreting a variety of adipokines affecting, for example, adiposity and insulin resistance. This proof of principle work focuses on the development of novel lipid-mimetic prodrugs reaching fat deposits by the same lymphatic absorption route followed by dietary triglycerides. Pterostilbene, a natural phenolic compound with potential anti-obesity effects, was used as model “cargo”, attached via a carbamate group to an ω-aminodecanoate chain linked to either position 1 or position 2 of the glycerol moiety of synthetic triglycerides. The prodrugs underwent position-selective hydrolysis when challenged with pancreatic lipases in vitro. Pterostilbene-containing triglycerides as well as pterostilbene and its metabolites were present in the adipose tissue of mice fed an obesogenic diet containing one or the other of the derivatives. For the first time this approach is used to deliver an obesity antagonist to the adipose tissue. The results demonstrate the feasibility of delivering active compounds to adipose tissue by reversibly incorporating them into triglyceride-mimetic structures. Upon release in the target site these compounds are expected to exert their pharmacological activity precisely where needed.

DETECTION AND SYNTHESIS OF A SYNERGIST OF THE SEX PHEROMONE OF THE COTTON BOLLWORM

Buchina, I. K.,Kholbekov, O. Kh.,Abduvakhabov, A. A.

, p. 121 - 123 (2007/10/02)

The synergistic properties of docosa-5Z,17Z-diene - one of the by-products of the synthesis of the synthetic cotton bollworm pheromone - have been revealed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51309-10-5